Back

A new free radical scavenger, resorcimoline, prevents ischaemia/reperfusion injury in the heart

31 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease: from bench to bedside (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kazuhiro Ueno

Oita University Faculty of Medicine, Oita (Japan)

8 More presentations in this session

Presentation thumbnail
Platelet membrane coated r-SAK to improve thrombolytic efficacy by targeting thrombus
Miss R. Hua (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
AtheroVax: a peptide vaccine with a therapeutic effect in animal model of chronic inflammation
Professor E. Ramacciotti (Santo Andre, BR)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitor attenuates left ventricular dysfunction in post-myocardial infarction in rats via reducing cardiac mitochondrial impairment
Doctor C. Maneechote (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Impact of dapagliflozin on cardiometabolic outcomes after myocardial infarction according to baseline glycaemic status and body mass index: a DAPA-MI substudy
Professor R. Storey (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
A randomized, double-blind, placebo-controlled, mechanistic trial on the safety, tolerability and pharmacodynamics of ninerafaxstat in patients with angina and chronic coronary syndrome
Doctor A. Saraste (Turku, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease: from bench to bedside (1)

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Nicorandil activates lkb1-ampk signaling pathway to ameliorate cardiac remodeling after myocardial ischemia/reperfusion injury by upregulating mt2
thumbnail
Congress Presentation
Novel first-in-class drug candidate protects from ischemia-reperfusion injury by targeting the SERCA2 complex
thumbnail
Congress Presentation
PPAR alpha-driven CISD2 upregulation by hesperetin protects against myocardial ischemia/reperfusion injury

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources